Price loading...

Horizons in Cancer Research: Volume 69 (Horizons in Cancer Research)

Oncology

Price data last checked 101 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

Horizons in Cancer Research. Volume 69 opens with a discussion on hypothetical mechanisms of the induction of NKreg cells in cancer and possible approaches to their abrogation, suggesting that for profound understanding of the problem of NKregs in the context of future target cancer immunotherapy, extensive clinical observations of NKreg cells should be carried out. Afterwards, the authors focus on the cell surface molecules in adult T-cell leukemia/lymphoma (ATL) cells, the function of matricellular proteins, particularly OPN, and their potential as targets for ATL immunotherapy. Later, the book demonstrates dual distinct functional roles of widespread cancerous immunoglobulins among cancer cells for the potential applications of RP215 in therapeutic treatments of many human cancers. RP215-linked chimeric antigen receptor (CAR)-T cell therapy technology has been applied in anti-cancer treatments through a series of CAR construction and validations by cytotoxic cell killing and cytokine activity release assays. Next, the authors present a new approach to describing, analyzing and understanding the process of dying in cancer patients based on the assumption that there are four tracks along which dying proceeds: the track focused on the medical-diagnostic aspects of the disease, the track referring to the physical aspects of the disease, the track defined by the psychological aspects of the disease and the track describing the coping- determined aspects of dying. In a separate study, examples of cases using a flexible, inflatable multi-channel applicator for the treatment of primary and recurrent gynecologic cancer, as well as treatment with Syed interstitial brachytherapy are presented. The examples are intended to emphasize the different characteristics of patients anatomy and tumors that guide the selection of a particular applicator and brachytherapy technique. Afterwards, the role of emodin in cancer prevention is discussed. Emodin possesses a broad spectrum of pharmacological, anticancer, anti-inflammatory, antioxidant and antimicrobial activities.

Product Specifications

Format: hardcover
ASIN: 1536132969
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 01 April 2018
Listed Since: 13 January 2018

Barcode

No barcode data available

Horizons in Cancer Research: Volume 69 (Horizons in Cancer Research)

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

Horisons in Cancer Research: Volume 61 - Nova Science Publishers

Horizons in Cancer Research: Volume 71

Horizons in Cancer Research: Volume 68

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Tissue Stiffness as a Risk of Cancer Development and Impact on Clinical Outcome in Solid Tumors: A Systematic Review (Cancer Etiology, Diagnosis and Treatments)

Horizons in Cancer Research. Volume 73: Volume 73

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana Combination Cancer Therapy: Modulators and Potentiators

CRC Press Rediscovering Cancer: From Mechanism to Therapy

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Mechanisms of Oncogenesis: An update on Tumorigenesis: 12 (Cancer Growth and Progression, 12)

Rediscovering Cancer: From Mechanism to Therapy

From Molecular to Modular Tumor Therapy:: Tumors are Reconstructible Communicatively Evolving Systems: 3 (The Tumor Microenvironment, 3)

Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy (Volume 18) (Cancer Sensitizing Agents for Chemotherapy, Volume 18)

Advances in Cancer Research: 79: Volume 79 (Advances in Cancer Research, Volume 79)

Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy)

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Cancer Stem Cells: New Horizons in Cancer Therapies

Pharmaceutical Perspectives of Cancer Therapeutics

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Pancreatic Cancer: Methods and Protocols: 980 (Methods in Molecular Biology, 980)

Hematopoietic Growth Factors in Oncology: 157 (Cancer Treatment and Research, 157)